Case Report: Prolonged VV-ECMO (111 Days) Support in a Patient With Severe COVID-19
Zhiheng Xu, Yonghao Xu, Dongdong Liu, Xuesong Liu, Xuesong Liu, Liang Zhou, Yongbo Huang, Yimin Li, Xiaoqing Liu, Xiaoqing Liu
Abstract
Venovenous extracorporeal membrane oxygenation (VV-ECMO) may be a lifesaving rescue therapy for patients with severe coronavirus disease 2019 (COVID-19). However, little is known regarding the efficacy of prolonged ECMO (duration longer than 14 days) in patients with COVID-19. In this case report, we report the successful use of prolonged VV-ECMO (111 days) in a 61-year-old man with severe COVID-19. Given the high mortality rate of severe COVID-19, this case provided evidence for use of prolonged VV-ECMO as supportive care in patients with severe COVID-19.
Topics & Concepts
Extracorporeal membrane oxygenationCoronavirus disease 2019 (COVID-19)MedicineRescue therapy2019-20 coronavirus outbreakSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)AnesthesiaSurgeryDiseaseInternal medicineVirologyInfectious disease (medical specialty)OutbreakMechanical Circulatory Support DevicesSARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studies